2341-4545 2341-4545 S2341-45452022000100022 10.1159/000516672 Portugal United Kingdom Canada Germany 28 02 2022 28 02 2022 29 1 22 30

1 2013 59 1 1 74-80 2 U 2002 137 12 12 947-54 3 O'Grady JG.Schalm SW.Williams R 1993 342 8866 8866 273-5 4 2013 369 26 26 2525-34 5 2015 80 3 3 599-606 6 2002 17 ^s3 ^s3 3 S268-73 7 Acute Liver Failure Study Group Germany 2012 10 6 6 664-9 8 2018 26 1 1 33-9 9 2017 39 25-30 10 Acute Liver Failure Study Group 2016 11 5 5 11 EASL Governing Board representative 2017 66 5 5 1047-81 12 American Association for the Study of Liver Disease 2005 41 5 5 1179-97 13 2018 93 3 3 360-6 14 2012 40 2 2 441-9 15 2019 11 7 7 586-95 16 2016 22 33 33 7595-603 17 de la Mata MSpanish Group for the Study of Acute Liver Failure 2007 13 10 10 1389-95 18 US Acute Liver Failure Study Group 2015 35 2 2 370-80 19 2019 49 7 7 874-85 20 2008 359 3 3 285-92 21 Acute Liver Failure Study Group 2009 137 3 3 856-64 22 1991 324 26 26 1852-7 23 Acute Liver Failure Study Group 2013 33 9 9 1324-31 24 Pediatric Acute Liver Failure Study Group 2013 57 4 4 1542-9 25 2015 5 ^s1 ^s1 1 S96-103 26 2018 29 2 2 280-90 27 U S Acute Liver Failure Study Group 2014 42 5 5 1157-67 28 2015 62 1 Suppl 1 Suppl S112-20 29 2007 46 6 6 1844-52 30 2016 65 2 2 273-9 31 2004 39 2 2 464-70 32 1982 23 7 7 625-9 33 1986 2 1 1 43-51 34 2002 36 33A 35 2009 136 7 7 2159-68 36 US Acute Liver Failure Study Group 2018 67 2 2 711-20 37 2013 159 8 8 522-31 38 2016 32 3 3 439-51 39 2016 64 1 1 69-78 40 US Acute Liver Failure Study Group 2014 12 11 11 1942-9 41 2003 125 3 3 755-64 42 2000 32 4 4 734-9 43 2014 90 4 4 240-7 44 1993 18 6 6 1370-6 45 2017 23 23 23 4303-10 46 2009 50 2 2 306-13 47 O'Grady J 2012 57 2 2 288-96